 | FAKHRAVAC (Persian: واکسن فخرا) is a COVID-19 vaccine developed in Iran by the Organization of Defensive Innovation and Research, a subsidiary of Iran's... 8 KB (517 words) - 05:29, 27 March 2024 |
Full (0) Emergency (1) India Travel-only Malaysia New Zealand Turkey FAKHRAVAC (or MIVAC), is an inactivated virus vaccine developed in Iran by the Organization... 318 KB (19,351 words) - 20:00, 21 April 2024 |
Medical Sciences Inactivated China June 2021 ZyCoV-D DNA India August 2021 FAKHRAVAC Inactivated Iran September 2021 COVAX-19 Subunit Australia, Iran October... 192 KB (21,930 words) - 19:29, 15 April 2024 |
the organization developed Iran's first COVID-19 testing kits and also FAKHRAVAC, a COVID-19 vaccine. Gambrell, Jon (2020-11-27). "Iran scientist linked... 5 KB (404 words) - 18:49, 1 March 2022 |
 | received emergency use authorization (COVIran Barekat, Pasteurcovac, FAKHRAVAC, COVAX-19 and Razi Cov Pars). The new drugs launched in Iran for the treatment... 37 KB (3,558 words) - 01:11, 25 January 2024 |
| Barekat (delivery unfulfilled) Sinopharm BIBP Pfizer Johnson and Johnson FAKHRAVAC Noora "Iranian capital Tehran holds first public Friday Prayers in almost... 13 KB (631 words) - 12:19, 30 March 2024 |
"great strides in the field of developing COVID-19 vaccine", later named FAKHRAVAC. He added that the center led by Fakhrizadeh went through the first phase... 105 KB (9,232 words) - 20:27, 19 April 2024 |
of Medical Sciences CoronaVac Covaxin COVIran Barekat CoviVac (Russia) FAKHRAVAC Minhai QazCovid-in Sinopharm BIBP Sinopharm WIBP Turkovac Valneva mRNA... 181 KB (23,901 words) - 14:23, 6 January 2024 |
 | developed in collaboration with Cuba, received EUA in Iran on 29 June 2021. FAKHRAVAC: received EUA on 9 September 2021. COVAX-19: developed in collaboration... 240 KB (18,865 words) - 08:40, 14 March 2024 |
| Academy of Medical Sciences, CoronaVac, Covaxin, CoviVac, COVIran Barekat, FAKHRAVAC, Minhai-Kangtai, QazVac, Sinopharm BIBP, WIBP, Turkovac, and VLA2001.... 98 KB (20,593 words) - 02:58, 8 March 2024 |